Showing results (151-160 of 291) with videos related to
Sort By:
Pageof 30
Blood|August 1, 1995
Rapid diagnosis of acute promyelocytic leukemia by immunohistochemical localization of PML/RAR-alpha proteinJ A Dyck, R P Warrell, R M Evans, et al.Leukemia|January 1, 1995
Pilot study of all-trans retinoic acid as post-remission therapy in patients with acute promyelocytic leukemiaK Seiter, W H Miller, E J Feldman, et al.The Canadian Veterinary Journal = La Revue Veterinaire Canadienne|October 1, 1994
Efficacy of tylosin tablets for the treatment of pyoderma due to Staphylococcus intermedius infection in dogsD W Scott, W H Miller, S M Cayatte, et al.Oncogene|February 19, 1999
Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin AP L Yeyati, R Shaknovich, S Boterashvili, et al.Cancer|December 15, 1990
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumorsR J Motzer, K Cooper, N L Geller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1987
Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosisE Dmitrovsky, M J Matthews, P A Bunn, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Expression of retinoic acid receptor beta in human renal cell carcinomas correlates with sensitivity to the antiproliferative effects of 13-cis-retinoic acidA D Hoffman, D Engelstein, T Bogenrieder, et al.Genes, Chromosomes & Cancer|March 1, 1990
Cytogenetic and molecular analysis of human male germ cell tumors: chromosome 12 abnormalities and gene amplificationF Samaniego, E Rodriguez, J Houldsworth, et al.American Journal of Clinical Oncology|August 1, 1990
A phase II trial of carboplatin (CBDCA) in small-cell and non-small-cell lung cancer with correlation to in vitro analysis of cytotoxicityE Dmitrovsky, E J Seifter, A F Gazdar, et al.Advances in Cancer Research|July 25, 2016
H3K27 Methylation: A Focal Point of Epigenetic Deregulation in CancerJ N Nichol, D Dupéré-Richer, T Ezponda, et al.Pageof 30